No. | Gender /age(yrs) | Site | Histology | Length (cm) | Fixation | Bony union (months) | MSTS score (%) | Complications (time;treatment) | Follow-up (months) | Outcome |
---|---|---|---|---|---|---|---|---|---|---|
1 | F/54 | tibia | lymphoma | 7.5 | nail | 7 | 100 | superficial infection (2 weeks po; debridement) | 52 | AWD |
2 | M/59 | humerus | Metastasis (lung) | 6 | plate | 10 | 93 | Â | 45 | AWD |
3 | F/21 | femur | osteosarcoma | 12 | plate | 8 | 83 | Â | 118 | NED |
4 | M/59 | femur | malignant peripheral schwannoma | 13 | nail | 6 | 90 | recurrence (24 months po; resection) | 32 | DOD |
5 | F/16 | tibia | osteosarcoma | 10 | nail | 12 | 80 | Â | 28 | DOD |
6 | F/17 | femur | osteosarcoma | 15 | plate | 9 | 83 | Â | 28 | DOD |
7 | M/16 | tibia | Ewing’s sarcoma | 8 | plate | 4 | 93 |  | 54 | NED |
8 | F/19 | humerus | malignant peripheral schwannoma | 12.5 | nail | 6 | 90 | recurrence (30 months po; amputation) | 44 | NED |
9 | M/26 | humerus | chondrosarcoma | 10 | plate | 8 | 86 | Â | 92 | NED |
10 | M/19 | tibia | Ewing’s sarcoma | 11 | nail | 10 | 90 |  | 36 | NED |
11 | F/51 | humerus | chondrosarcoma | 11.5 | plate | 10 | 93 | Â | 88 | NED |
12 | F/68 | tibia | Metastasis (breast) | 12 | nail | 12 | 86 | Â | 12 | DOD |
13 | M/14 | tibia | Ewing’s sarcoma | 8 | plate | 8 | 76 | leg shortening, 4 cm (shoe lifts) | 42 | NED |
14 | F/15 | tibia | malignant peripheral schwannoma | 10 | plate | 8 | 83 | Â | 60 | NED |
15 | M/71 | ulna | Metastasis (kidney) | 9 | plate | 10 | 96 | Â | 20 | DOD |
16 | M/22 | femur | osteosarcoma | 25 | plate | 15 | 80 | fracture (54 months po; prosthesis) | 75 | NED |
17 | M/70 | femur | Metastasis (lung) | 24 | plate | - | 86 | nonunion (17 months po; die of disease) | 17 | DOD |
18 | F/49 | femur | Metastasis (multiple Myeloma) | 14.5 | nail | 8 | 86 | Â | 127 | AWD |
19 | F/14 | tibia | osteosarcoma | 12 | plate | 5 | 96 | Â | 56 | NED |
20 | F/32 | tibia | synovial sarcoma | 6 | plate | 6 | 93 | Â | 53 | DOD |
21 | M/55 | femur | chondrosarcoma | 15 | nail | 7 | 80 | recurrence (36 months po; prosthesis) | 40 | NED |
22 | F/45 | tibia | malignant fibrous histiocytoma | 8 | plate | 6 | 93 | Â | 36 | DOD |
23 | M/16 | femur | Ewing’s sarcoma | 16 | nail | 8 | 90 |  | 32 | DOD |
24 | M/16 | femur | osteosarcoma | 18 | nail | 10 | 93 | Â | 50 | DOD |
25 | M/17 | tibia | chondrosarcoma | 7.5 | plate | 11 | 86 | Â | 63 | NED |
26 | F/22 | tibia | synovial sarcoma | 13 | plate | 18 | 96 | Â | 126 | NED |
27 | M/56 | humerus | malignant fibrous histiocytoma | 11 | nail | 9 | 90 | Â | 30 | DOD |
28 | M/76 | tibia | lymphoma | 11 | nail | 8 | 70 | deep infection (13 months po; amputation) | 33 | DOD |
29 | F/17 | tibia | malignant fibrous histiocytoma | 9.5 | plate | 10 | 90 | Â | 48 | NED |
30 | F/15 | tibia | osteosarcoma | 10 | plate | 10 | 70 | Fracture (30 months po; internal fixation and allograft) | 32 | NED |
31 | M/31 | tibia | fibrosarcoma | 11 | nail | 6 | 86 | Â | 14 | NED |
32 | F/34 | femur | synovial sarcoma | 10 | nail | 5 | 86 | Â | 42 | DOD |
33 | F/55 | tibia | Metastasis (lung) | 7 | nail | 11 | 83 | Â | 22 | DOD |